MedTrace Logo

Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay

NCT01214512 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 229

Last updated 2013-03-12

No results posted yet for this study

Summary

This study is aimed to evaluate the performance of the Micromedic CD24 assay in identifying colorectal adenoma using Western blot and ELISA assays. These assays are designed to detect CD24 protein in peripheral blood leukocytes (PBL). Elevated levels of CD24 may be indicative of colorectal adenoma (inclusive of optically detectable early adenoma to late adenoma, and cancer).

Conditions

Interventions

OTHER

blood-sample based diagnostic assay

A blood sample will be used in a Western blot and ELISA assay to determine CD24 levels

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01214512 on ClinicalTrials.gov